湖南汉森制药股份有限公司2025年第一次临时股东大会决议公告

Meeting Overview - The first extraordinary general meeting of shareholders for Hunan Hansen Pharmaceutical Co., Ltd. was held on November 13, 2025, combining on-site voting and online voting [4][5][6] - A total of 102 shareholders and their authorized representatives attended the meeting, representing 221,226,929 shares with voting rights, accounting for 43.9640% of the total voting shares [7] Resolutions Passed - The meeting approved several proposals, including amendments to the company's articles of association and various management systems [10] - Specific proposals that received approval include revisions to the rules for shareholder meetings, board meetings, independent director work systems, related party transaction management, external guarantee management, external investment management, dividend management, and fundraising usage management [10] Legal Compliance - The meeting's procedures, including the qualifications of the conveners and attendees, voting procedures, and results, were confirmed to be in compliance with the Company Law and other relevant regulations [12] Election of Employee Representative Director - The fourth second employee representative meeting elected Ms. Hu Qiong as the employee representative director for the sixth board of directors, with her term lasting until the board's term ends [13] - Ms. Hu Qiong's election complies with regulations regarding the composition of the board, ensuring that the number of employee representatives does not exceed half of the total board members [13]